NIH Agrees to $1.4 million in Funding for 23andMe.
Less than a year since the US Food and Drug Administration ordered 23andMe, the leading personalized genetic testing company to cease and desist in DNA testing without the proper medical protocols, the National Institute of Health (“NIH”) has awarded the company a $1,367,504 for a two-year project to support the further development of 23andMe’s web-based […]
This is a cutting edge concept that researchers should consider to counter the effects of Eroom’s Law. For all you computer nerds, yes, that is Moore’s Law spelled backwards. Eroom’s Law works on the idea that the number of new drugs approved by the US Food and Drug Administration (FDA) per billion US dollars spent […]
The inevitable use of smartphones and mobile devices are making their way into our every day lives and are helping people manage their health outcomes. The National Institutes of Health has started a new mhealth grants program offering awards of up to $500,000. The NIH is a accepting applications today through May. Technologies that address self management of […]
St. Louis has all of the ingredients to make it to the next level. Four major universities that are pumping our new technologies in health and bioscience, a willingness to invest in themselves and most important have learned the need to “collaborate.”
New Orleans: Citing a strong local economy and the lower cost of doing business in the South, New Orleans tied San Antonio as the #1 cities for attracting college grads 2007-2012. The city’s post-Katrina redevelopment and expansion of the film, technology and the biotech industries have given rise to Economist Joel Louisiana offers the country’s […]
GEN’s algorithm ranked the top locations that included many of the up-and-coming smaller clusters which are showing major advances. The European cluster building deploys the organizing principle of Subsidiarity, which increases the opportunity for accelerated growth. The closer the governing authority the faster decision process. One notable example was Norway’s Oslo Cancer Cluster which […]